Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Operating Expenses | 6,500 | 6,680 | 5,000 | 5,060 | 5,100 |
Operating Income | -6,500 | -6,680 | -5,000 | -5,060 | -5,100 |
Other Income | 2,990 | -280 | -770 | 2,180 | 280 |
Pre-tax Income | -3,510 | -6,960 | -5,770 | -2,880 | -4,820 |
Net Income Continuous | -3,519 | -7,180 | -5,776 | -2,886 | -4,827 |
Net Income | $-3,519 | $-7,180 | $-5,776 | $-2,886 | $-4,827 |
EPS Basic Total Ops | -3.00 | -4.50 | -6.00 | -0.30 | -4.50 |
EPS Basic Continuous Ops | -3.00 | -4.50 | -6.00 | -0.30 | -4.50 |
EPS Diluted Total Ops | -3.00 | -4.50 | -6.00 | -0.30 | -4.50 |
EPS Diluted Continuous Ops | -3.00 | -4.50 | -6.00 | -0.30 | -4.50 |
EBITDA(a) | $-6,500 | $-6,680 | $-5,000 | $-5,160 | $-5,000 |